Thrombosis
News
VTE is ‘major contributor’ to global disease burden
Credit: Andre E.X.
News
Inflammatory rheumatic diseases raise venous thromboembolism risk
Key clinical point: There is strong evidence for an elevated baseline risk of VTE in patients with inflammatory rheumatic diseases. Major finding...
News
Coating repels blood and bacteria
to form a blood clot Credit: James Weaver Researchers have developed a coating that can prevent blood and bacteria from adhering to the surface...
News
Results of VTE prophylaxis vary in otolaryngology patients
The effectiveness of thromboprophylaxis in otolaryngology patients undergoing surgery differs based on patient risk and the procedure, a new study...
News
Research could aid platelet production
in the bone marrow Scientists say they’ve shed new light on the mechanism of platelet formation, paving the way to accelerating and enhancing...
Conference Coverage
Rivaroxaban rivals standard for VTE in cancer
Credit: CDC MADRID—A pooled analysis of 2 studies suggests rivaroxaban prevents recurrent venous thromboembolism (VTE) in cancer patients as...
News
Self-monitoring coagulometers get thumbs-up from NICE
The UK’s National Institute for Health and Care Excellence (NICE) has published a guidance recommending 2 technologies that enable patients on...
News
Platelets respond to their surroundings, study shows
Credit: Andre E.X.
News
FDA approves 30-day pack of anticoagulant
Credit: NHS The US Food and Drug Administration (FDA) has approved the Xarelto Starter Pack™ for the treatment of deep vein thrombosis (DVT) and/...
News
Studies explain gene’s role in thrombosis, hemostasis
Credit: Kevin MacKenzie Two preclinical studies provide new insight into the activity of STXBP5, a gene that has been linked to changes in von...
Conference Coverage
Longer duration of triple therapy confers no benefit, trial suggests
Credit: Sage Ross WASHINGTON, DC—Six weeks of triple anticoagulant therapy may be sufficient in patients who have received a drug-eluting stent...